Zika Virus Vaccines

The Live-Attenuated vaccine is developed to the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos.  The understanding of flavivirus particle structure, definition of E dimers as the key antigenic target, and deep understanding of neutralization mechanisms help to develop the vaccine.

  • Zika Virus Vaccine Development
  • Zika Virus Vaccines Recent Research
  • Zika Virus Vaccines Clinical Trials
  • Zika Virus Vaccine in Pregnant Women
  • Purified Inactivated Vaccine
  • DNA Vaccine
  • Live Attenuated Vaccine
  • DNA and mRNA Vaccine

Related Conference of Zika Virus Vaccines

June 09-09, 2021

Global Summit on Vaccines and Immunology

Chicago, USA
June 09-10, 2021

Global Summit on HIV-AIDS and STDs

Chicago, USA
June 09-10, 2021

Global Summit on Vaccines & Emerging Diseases

Chicago, USA
June 14-15, 2021

Global Summit on Hepatitis Vaccine

Rome, Italy
July 29-30, 2021

33rd Annual Congress on Immunology and Vaccinations

Vancouver, Canada

Zika Virus Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in